NCT00320762View on ClinicalTrials.gov

Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

December 31, 2007

Conditions
GlaucomaPterygium
Interventions
DEVICE

OculusGen Biodegradable Collagen Matrix Implant

Trial Locations (1)

100730

Beijing Hospital, Beijing

All Listed Sponsors
lead

Pro Top & Mediking Company Limited

INDUSTRY

NCT00320762 - Ologen (OculusGen)-Glaucoma and Pterygium Historical Control Study in China Beijing Hospital | Biotech Hunter | Biotech Hunter